
Cracking the Code: Genetic Testing and Continuous Spike-Waves During Slow Sleep
Explore how genetic testing can revolutionize CSWS management, providing insights for diagnosis, personalized treatment, and informed family planning decisions.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Explore how genetic testing can revolutionize CSWS management, providing insights for diagnosis, personalized treatment, and informed family planning decisions.

Unravel the genetic basis of CPVSF1B. Understand diagnosis, benefits of early detection, and family planning with MYH3 gene insights in this rare disorder.

Explore how genetic testing revolutionizes craniopharyngioma treatment by enabling early detection, personalized therapies, and improved patient outcomes.

Unlock insights into Cushing syndrome's genetics with testing. Identify mutations, enable personalized treatments, and explore ARMC5's role in managing adrenal hyperplasias.

Genetic testing for cutaneous mastocytosis aids in diagnosis, personalized treatment, and predicting disease progression, enhancing management and patient outcomes.

Explore Cutis Laxa, Autosomal Dominant, and its genetic testing benefits for accurate diagnosis, personalized treatment, and informed family planning.

Explore how genetic testing revolutionizes DEND syndrome management, enhancing diagnosis, treatment, and patient empowerment through precision medicine.

Unlock the potential of genetic testing in diagnosing and personalizing treatment for Desmoplastic Small Round Cell Tumor, a rare, aggressive cancer.